Literature DB >> 9973387

Lymphotoxin alphabeta is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation.

I Gramaglia1, D N Mauri, K T Miner, C F Ware, M Croft.   

Abstract

Lymphotoxin (LT) is a cytokine that orchestrates lymphoid neogenesis and formation of germinal center reactions. LT exists as a membrane heterotrimer of alpha and beta subunits and is secreted as a homotrimer, LTalpha3. Using LTbetaR.Fc, expression of LTalphabeta on CD4 T cell subsets was investigated in a TCR transgenic model. LTalphabeta was evident 24-72 h after activation of naive T cells with specific Ag, and declined thereafter. Early expression was independent of IFN-gamma and IL-12, however, IL-12 prolonged expression. LTalphabeta was reinduced within 2-4 h after Ag restimulation, but declined by 24 h regardless of IL-12 or IFN-gamma priming. Exposure of naive T cells to IL-4 did not affect early LTalphabeta expression at 24 h, but resulted in subsequent down-regulation. IL-4-differentiated Th2 effectors did not re-express LTalphabeta, and LTalphabeta was transiently found on Th1 clones but not Th2 clones. LTalpha3 and TNF were immunoprecipitated from supernatants and lysates of IL-12 primed cells but not IL-4 primed cells. These studies demonstrate that LTalphabeta is expressed by activated naive CD4 cells, unpolarized IL-2-secreting effectors, and Th1 effectors. In contrast, loss of surface LTalphabeta and a lack of LTalpha3 and TNF secretion is associated with prior exposure to IL-4 and a Th2 phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973387

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease.

Authors:  Eugene Y Chiang; Ganesh A Kolumam; Xin Yu; Michelle Francesco; Sinisa Ivelja; Ivan Peng; Peter Gribling; Jean Shu; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Andres Paler-Martinez; Allen Nguyen; Judy Young; Kai H Barck; Richard A D Carano; Ron Ferrando; Lauri Diehl; Devavani Chatterjea; Jane L Grogan
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

2.  Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT.

Authors:  John Bechill; William J Muller
Journal:  Mol Immunol       Date:  2014-06-28       Impact factor: 4.407

Review 3.  Keystones in lymph node development.

Authors:  Katrin S Blum; Reinhard Pabst
Journal:  J Anat       Date:  2006-11       Impact factor: 2.610

4.  The Absence of Lymphotoxin-α, a Herpesvirus Entry Mediator (HVEM) Ligand, Affects Herpes Simplex Virus 1 Infection In Vivo Differently than the Absence of Other HVEM Cellular Ligands.

Authors:  Shaohui Wang; Satoshi Hirose; Homayon Ghiasi
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

5.  Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis.

Authors:  Joel Crespo; Ke Wu; Wei Li; Ilona Kryczek; Tomasz Maj; Linda Vatan; Shuang Wei; Anthony W Opipari; Weiping Zou
Journal:  J Immunol       Date:  2018-05-25       Impact factor: 5.422

Review 6.  The lymphotoxin pathway: beyond lymph node development.

Authors:  Douglas D McCarthy; Leslie Summers-Deluca; Frances Vu; Sidney Chiu; Yunfei Gao; Jennifer L Gommerman
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 7.  Lymphotoxin signalling in immune homeostasis and the control of microorganisms.

Authors:  Vaibhav Upadhyay; Yang-Xin Fu
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

8.  Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.

Authors:  Jochem H Bernink; Charlotte P Peters; Marius Munneke; Anje A te Velde; Sybren L Meijer; Kees Weijer; Hulda S Hreggvidsdottir; Sigrid E Heinsbroek; Nicolas Legrand; Christianne J Buskens; Willem A Bemelman; Jenny M Mjösberg; Hergen Spits
Journal:  Nat Immunol       Date:  2013-01-20       Impact factor: 25.606

9.  Evidence that TNF-β suppresses osteoblast differentiation of mesenchymal stem cells and resveratrol reverses it through modulation of NF-κB, Sirt1 and Runx2.

Authors:  Buhrmann Constanze; Bastian Popper; Bharat B Aggarwal; Mehdi Shakibaei
Journal:  Cell Tissue Res       Date:  2020-03-06       Impact factor: 5.249

10.  Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14(+) monocytes in frail older adults.

Authors:  Tao Qu; Jeremy D Walston; Huanle Yang; Neal S Fedarko; Qian-Li Xue; Brock A Beamer; Luigi Ferrucci; Noel R Rose; Sean X Leng
Journal:  Mech Ageing Dev       Date:  2008-11-05       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.